This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2015-2018.
Company Filing History:
Years Active: 2015-2018
Title: Mohammed Shaheer Malik: Innovator in Anticancer and Antitubercular Research
Introduction
Mohammed Shaheer Malik is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential anticancer and antitubercular properties. With a total of 2 patents to his name, Malik is dedicated to advancing healthcare through innovative research.
Latest Patents
Malik's latest patents include two noteworthy inventions. The first patent focuses on N-((3,4,5-trimethoxystyryl)aryl)cinnamamide compounds as potential anticancer agents. This invention provides a compound of general formula A, which is useful against human cancer cell lines. The general formula A includes various selections for B, which can be aryl, heteroaryl, or fused heteroaryl rings, and X, which can be H, hydroxy, alkyl, alkoxy, prop-2-ynyloxy, allyloxy, halo, alkylhalides, alkoxy halides, nitro, or amine.
The second patent involves quinolylpiperazino substituted thiolactone compounds, which are designed as potential anti-tubercular agents against H37Rv and drug-resistant strains. This invention also provides a process for the preparation of these compounds, where n can range from 5 to 12, and R can be C or Cl.
Career Highlights
Malik is currently affiliated with the Council of Scientific and Industrial Research, where he continues to engage in groundbreaking research. His work is characterized by a commitment to developing effective therapeutic agents that address critical health challenges.
Collaborations
Some of his notable coworkers include Ahmed Kamal and Vadithe Lakshma Nayak, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Mohammed Shaheer Malik is a dedicated inventor whose work in the field of medicinal chemistry is paving the way for new treatments in cancer and tuberculosis. His innovative patents reflect his commitment to improving health outcomes through scientific research.